The next in The Healthiest You series, this event was a collaboration with Swisse Wellness and the Australia China Health Accelerator (ACHA).
This timely session provided insights into the recovery path out of COVID-19 from an ophthalmological outlook, first-hand research on myopia (near-sightedness), as well as general eye health information, crucial for Australians as 55% of our population suffers from one or more long-term vision disorders.
We are grateful to Professor Andrew Wilson for taking time away from his demanding role on COVID recovery to update us on the situation and provide a forecast on the way forward. Andrew addressed the adverse effects COVID-19 has on the population including the reduction in numbers of individuals visiting their GPs (down 30%), impacting cancer screenings and crucial eye check-ups. He reiterated that responding to secondary impacts of the pandemic such as these will be a key part of our recovery.
ACBC Vic also gives our sincere thanks to Professor Mingguang He for sharing his ground-breaking research into myopia in East Asia. Some key takeaways from his talk can be found below.
Jason Sun, CEO of the ACHA closed the session by addressing the benefits of Australia-China medical collaboration, exhibited through Professor He’s work in Guangzhou. Having access to China’s market size is of huge benefit to Australian medical research. The landmark work being undertaken at various Victorian universities/medical institutions provides an incubator for world-leading cross-border medical collaboration. ACBC Vic is proud to support the work the ACHA is doing in this regard. Health and science knows no borders!
Some of Prof. Mingguang He’s key takeaways were: